ArticleJB & JS open access
Low Rates of Bone Health Evaluation Before and After Primary Fragility Fractures.
Article in JB & JS open access. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Osteoporotic fractures pose a critical challenge in patient care, with earlier work pointing to a significant shortfall in preventing subsequent fractures. This study aimed to determine the rate and predictors of bone health evaluations (BHE) before and after an operatively treated first-time fragility fracture and assess the imminent risk of a subsequent fracture. Methods: This retrospective cohort study at a level I trauma center included patients aged 60 years or older who underwent surgery for fragility fractures (hip, pelvis, wrist, humerus, or femur) due to low-energy mechanisms between 2012 and 2022. Patients with a history of pathologic fractures, malignancies, or metabolic and autoimmune diseases affecting bone density were excluded. Demographic data, medical history, and details regarding BHE and fracture characteristics were collected. BHE was defined as a specialist-led management/education session, with or without a dual-energy X-ray absorptiometry scan. Results: Six hundred two patients (71% female; median age 78 [interquartile ranges {IQR}: 68-87]) with primary fragility fractures were identified. Within this cohort, only 13 (2.2%) had a documented BHE before fracture. Of the remaining 589 patients, 178 (30.2%) were referred for BHE after primary fragility fracture, but only 27 (4.6%) received it. Secondary fragility fractures were diagnosed in 69 patients (11.5%) after an average of 2.2 years (IQR: 1.04-3.75). Among this group, no statistically significant differences were found about patient characteristics or demographics. When comparing patients with and without secondary fragility fractures, there was no statistically significant difference in the overall rate of BHEs. Younger patients (p = 0.015) or those with a family history of osteoporosis (p < 0.001) were more likely to seek BHE. Conclusion: There is a marked scarcity of BHEs both before and after primary fragility fractures, despite the established risks. Much work needs to be performed to improve referral and patient participation in BHEs after a first-time fragility fracture.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.